Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma:A Phase I/II Investigator-Initiated Clinical Trial
Phase of Trial: Phase I/II
Latest Information Update: 03 Jun 2019
At a glance
- Drugs Mepacrine (Primary) ; Capecitabine
- Indications Adenocarcinoma; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- 03 Jun 2019 Results (n=10) published in conjunction with the 55th Annual Meeting of the American Society of Clinical Oncology.
- 17 Sep 2018 Primary completion date changed to 1 Apr 2020.
- 17 Sep 2018 Planned number of patients changed from 30 to 35.